Demo Data from EDBT 2026 / reviewers in the wild / expert
Peter K. Harris
dblp:370/5274
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2023
—ORCID · unresolved
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% | |
| Computer architecture, parallel and distributed computing, and storage systems
1 paper |
Distributed systems · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › cancer genomics
circulating tumor DNA analysis |
0.7 | 1 | 2023 | PACT: a pipeline for analysis of circulating tumor DNA · Bioinform. 2023 |
Bioinformatics and computational biology › genomics › structural variation
structural variant detection |
0.7 | 1 | 2023 | PACT: a pipeline for analysis of circulating tumor DNA · Bioinform. 2023 |
Distributed systems
workflow management |
0.2 | 1 | 2023 | PACT: a pipeline for analysis of circulating tumor DNA · Bioinform. 2023 |
Methods — techniques the papers use, named apart from their topics
common workflow language · 1.3
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2023 | PACT: a pipeline for analysis of circulating tumor DNAabstractMOTIVATION: Detection of genomic alterations in circulating tumor DNA (ctDNA) is currently used for active clinical monitoring of cancer progression and treatment response. While methods for analysis of small mutations are more developed, strategies for detecting structural variants (SVs) in ctDNA are limited. Additionally, reproducibly calling small-scale mutations, copy number alterations, and SVs in ctDNA is challenging due to the lack to unified tools for these different classes of variants. RESULTS: We developed a unified pipeline for the analysis of ctDNA [Pipeline for the Analysis of ctDNA (PACT)] that accurately detects SVs and consistently outperformed similar tools when applied to simulated, cell line, and clinical data. We provide PACT in the form of a Common Workflow Language pipeline which can be run by popular workflow management systems in high-performance computing environments. AVAILABILITY AND IMPLEMENTATION: PACT is freely available at https://github.com/ChrisMaherLab/PACT. Jace Webster, Ha X. Dang, Pradeep S. Chauhan, Wenjia Feng, Alex Shiang, Peter K. Harris, Russell K. Pachynski, Aadel A. Chaudhuri, Christopher A. Maher |
Bioinform. | 6 |